A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension

Autor: Gleim, Gilbert W., Rubino, Joseph, Zhang, Hongyan, Shahinfar, Shahnaz, Soffer, Beth A., Lyle, Paulette A., Littlejohn, Thomas W., III, Feig, Peter U.
Zdroj: In Clinical Therapeutics 2006 28(10):1639-1648
Databáze: ScienceDirect